ArticleRadiology case reports2025
A case of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal vasculopathy with cerebral leukoencephalopathy (RVCL) is an autosomal dominant disorder caused by mutations in the TREX1 gene, which affects medium and small arteries and veins. Reported in fewer than 50 families worldwide, RVCL typically affects individuals between 35 and 40 years of age. It commonly presents with vision disturbances due to retinal vasculopathy and neurological deficits from cerebral leukoencephalopathy. Tumefactive brain lesions are sometimes seen, which can resemble gliomas or tumefactive multiple sclerosis. RVCL is also associated with systemic manifestations, including Raynaud's phenomenon, anemia, migraines, psychological issues, and dysfunction of organs such as the kidneys, liver, gastrointestinal system, and thyroid. A positive family history is frequently noted. Early recognition of RVCL is crucial for preventing unnecessary invasive procedures, facilitating early diagnosis, and enabling family counseling. This report presents a case of RVCL-S that was initially misdiagnosed as a glioma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.